Clinical trial
Seroquel® Combined With Cognitive Remediation Therapy to Conventional Treatment…
NCT00255515 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00255515 |
|---|---|
| Title | Seroquel® Combined With Cognitive Remediation Therapy to Conventional Treatment in Patients With Schizophrenia |
| Official title | An Open, Randomised, Parallel, Three Treatment Groups, Multicentre, Phase IV Study - in Real Life - to Compare the Change in Social Outcome of Quetiapine Fumarate (Seroquel®) Combined With Cognitive Remediation Therapy to Conventional Treatment in Patients With Schizophrenia. |
| Acronym | SCORE |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Quetiapine fumarate, conventional treatment for schizophrenia |
| Enrollment | 85 |
| Start date | Sep 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Nov 21, 2005 |
| Last update posted | Mar 25, 2009 |
| Countries | Sweden |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: